Novavax, Inc. (NASDAQ:NVAX) shares surged more than 16% after the company shared a positive update on its COVID-19 vaccine, which it believes is “approvable” based on its conversations with the US Food and Drug Administration (FDA).
The company said the FDA has requested additional data on the vaccine as part of a post-marketing commitment (PMC).
General Mills Inc (NYSE:GIS, ETR:GRM) is headed for a challenging year, according to UBS, which initiated coverage on the packaged food giant with a ‘Sell’ rating and a 12-month price target of $54.
In a note to clients, analysts said both sales and earnings expectations for the maker of Cheerios and Pillsbury appear too high despite recent downward revisions.
Tempus AI (NASDAQ:TEM) said on Wednesday it has signed multi-year strategic collaborations with AstraZeneca (AZN.L) and Pathos AI to co-develop what it called the largest multimodal foundation model in oncology, sending its shares up more than 15% in morning trading.
The deals, which include $200 million in data licensing and model development fees to Tempus, will leverage the company’s vast repository of de-identified oncology data and artificial intelligence capabilities to help identify new drug targets and advance cancer therapies.
Tesla Inc (NASDAQ:TSLA)’s Optimus humanoid robot project could be delayed by restrictions on the export of rare earth minerals from China, CEO Elon Musk told investors during the company’s first quarter earnings call on Tuesday.
Describing the situation as a “magnet issue," Musk said that the production of Optimus relies on specialized rare earth magnets for the electric motors in the robot’s arms, components that now face new export licensing challenges.
Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF) announced that it has begun the market introduction of its new line of barium contrast media products in Canada and select international markets that accept Health Canada standards.
The company is targeting jurisdictions aligned with Health Canada standards for initial distribution and is now providing product samples to diagnostic centers for evaluation.
Philip Morris International Inc (NYSE:PM, ETR:4I1) has raised its earnings outlook for 2025 and delivered an earnings beat for the first quarter, sending its shares almost 3% higher on Wednesday.
The multinational tobacco firm best known for its Marlboro cigarettes now expects adjusted earnings for the full year to be between $7.36 and $7.49 per share, representing growth of 12% to 14%, up from its previous forecast of $7.04 to $7.17 per share.
Boeing Co (NYSE:BA, ETR:BCO) shares gained more than 7% on Wednesday as the airplane manufacturer’s first quarter earnings and production update impressed investors.
The company said Q1 revenue increased 18% year-over-year to $19.5 billion, in line with Street estimates.
Gold stocks gave back some of their recent gains on Wednesday after prices for the metal fell sharply in response to more conciliatory comments from US President Donald Trump.
Spot gold dropped 2.6% to $3,329 an ounce in mid-morning trading, pulling back from Tuesday’s all-time high of $3,500.05.
Hochschild Mining PLC (LSE:HOC, OTCQX:HCHDF) shares tumbled 12% after the gold miner revealed that the rainy season impacted output at Brazil's Mara Rosa operation more than expected.
The South American precious metals miner produced 80koz attributable gold equivalent in the first quarter of 2025, a little softer than analysts had forecast.
Shares in Ethernity Networks Ltd (AIM:ENET, OTCQB:ENETF) soared 83% in early trading on Wednesday after the networking specialist unveiled a strategic shift and signalled early interest from major telecoms vendors.
While full-year revenue fell to $1.38 million in 2024 from $3.78 million, and losses narrowed modestly, investors focused on signs of traction for the company’s UEP-2025 platform.